Acentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access Commission
May 02 2024 - 11:54AM
Acentra Health, a Virginia-based technology solutions and clinical
services company dedicated to helping government healthcare
agencies accelerate better health outcomes, announced today that
Acentra Health Executive Vice President and Chief Strategy Officer
Verlon Johnson, MPA, has been appointed Chair of the Medicaid and
CHIP Payment and Access Commission (MACPAC) by the U.S. Government
Accountability Office (GAO). In addition, she was reappointed to
serve a second consecutive three-year term as a MACPAC
commissioner.
MACPAC is a non-partisan advisory committee established in 2009
to advise Congress, the Secretary of the U.S. Department of Health
and Human Services, and states on policy and access issues related
to Medicaid and the Children’s Health Insurance Program (CHIP). Its
17 commissioners are chosen from diverse regions across the nation
and bring broad expertise and perspectives on Medicaid and
CHIP.
Johnson is a nationally recognized expert in government
healthcare programs and has devoted her career to improving access
to Medicaid. Prior to Acentra Health, Johnson spent nearly 25 years
in federal service, including serving as the Associate Consortium
Administrator for Medicaid and CHIP at the Centers for Medicare
& Medicaid Services (CMS), Acting Regional Director for the
U.S. Department of Health and Human Services, and in multiple
leadership roles across numerous CMS regions. In addition, she
served as Vice President of Healthcare Policy and Management for
IBM Watson Health’s government health and human services business
group, where she provided strategic direction for innovation and
improvements to Medicaid, Medicare, and private insurance.
In her role as Chief Strategy Officer for Acentra Health,
Johnson serves on the company’s executive leadership team and
oversees the company’s growth strategy, including organic growth
and acquisitions. Her role includes advising on innovations that
will help Acentra Health support its clients and accelerate better
health outcomes through technology, services, and clinical
expertise.
“I am deeply humbled and profoundly honored to have my name
mentioned alongside such an exceptional team of commissioners and
staff,” said Verlon Johnson, incoming MACPAC Chair. “Collaborating
with this dedicated group to enhance Medicaid and CHIP is a
privilege that fills me with great pride, especially as our work
aims to improve the lives of the millions who rely on these vital
programs.”
“Verlon’s reappointment and selection as MACPAC Chair is an
outstanding recognition of her nearly three decades of service in
public and private sector healthcare,” said Todd Stottlemyer, CEO,
Acentra Health. “She is passionate about working with government
organizations to make access to quality healthcare a basic human
right.”
“I was pleased to lend my recommendation three years ago for
Verlon’s first appointment as MACPAC Commissioner and commend the
GAO for recognizing her contributions by appointing her as Chair,”
said U.S. Senator Mark R. Warner. “We value the input that MACPAC
has provided to Congress on issues affecting Medicaid and CHIP, and
that is because of the recognized expertise and diverse
perspectives that commissioners like Verlon have demonstrated as
trusted advisors.”
Read more about the MACPAC’s new commission appointments
here.
About Acentra Health
Acentra Health combines public sector knowledge, clinical
expertise, and technological ingenuity to modernize the healthcare
experience for state and federal partners and their priority
populations. From designing and developing advanced claims,
encounter, and provider solutions that drive efficiency and cost
savings to delivering clinically focused service models for care
management and quality oversight, Acentra Health is accelerating
better outcomes. Acentra Health is backed by Carlyle (NASDAQ: CG),
a global investment firm. Learn more at acentra.com.
Media Contact:Janice MooreVice President, Corporate
Communications703-214-3552
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/84024834-ccd1-45f2-ab69-bd2fd11b4157
Carlyle (NASDAQ:CG)
Historical Stock Chart
From Apr 2024 to May 2024
Carlyle (NASDAQ:CG)
Historical Stock Chart
From May 2023 to May 2024